1. Home
  2. CASI vs NHTC Comparison

CASI vs NHTC Comparison

Compare CASI & NHTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CASI
  • NHTC
  • Stock Information
  • Founded
  • CASI 1991
  • NHTC 1988
  • Country
  • CASI China
  • NHTC United States
  • Employees
  • CASI N/A
  • NHTC N/A
  • Industry
  • CASI Biotechnology: Pharmaceutical Preparations
  • NHTC Diversified Commercial Services
  • Sector
  • CASI Health Care
  • NHTC Miscellaneous
  • Exchange
  • CASI Nasdaq
  • NHTC Nasdaq
  • Market Cap
  • CASI 35.8M
  • NHTC 56.0M
  • IPO Year
  • CASI 1996
  • NHTC 1995
  • Fundamental
  • Price
  • CASI $1.78
  • NHTC $4.54
  • Analyst Decision
  • CASI Strong Buy
  • NHTC
  • Analyst Count
  • CASI 1
  • NHTC 0
  • Target Price
  • CASI $4.00
  • NHTC N/A
  • AVG Volume (30 Days)
  • CASI 70.7K
  • NHTC 21.8K
  • Earning Date
  • CASI 11-13-2025
  • NHTC 10-29-2025
  • Dividend Yield
  • CASI N/A
  • NHTC 17.70%
  • EPS Growth
  • CASI N/A
  • NHTC N/A
  • EPS
  • CASI N/A
  • NHTC 0.03
  • Revenue
  • CASI $31,564,000.00
  • NHTC $42,087,000.00
  • Revenue This Year
  • CASI N/A
  • NHTC N/A
  • Revenue Next Year
  • CASI N/A
  • NHTC N/A
  • P/E Ratio
  • CASI N/A
  • NHTC $147.96
  • Revenue Growth
  • CASI 36.64
  • NHTC N/A
  • 52 Week Low
  • CASI $1.09
  • NHTC $4.02
  • 52 Week High
  • CASI $7.50
  • NHTC $6.80
  • Technical
  • Relative Strength Index (RSI)
  • CASI 36.52
  • NHTC 49.99
  • Support Level
  • CASI $2.18
  • NHTC $4.44
  • Resistance Level
  • CASI $2.49
  • NHTC $4.72
  • Average True Range (ATR)
  • CASI 0.18
  • NHTC 0.10
  • MACD
  • CASI -0.09
  • NHTC 0.00
  • Stochastic Oscillator
  • CASI 6.49
  • NHTC 47.50

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

About NHTC Natural Health Trends Corp.

Natural Health Trends Corp is an international direct-selling and e-commerce company. It offers a line of products such as Wellness, Herbal, Beauty, Lifestyle, and Home. Wellness products include targeted nutrition for joint health, antioxidant support, digestive health, heart health, and vision health. Herbal products include anti-aging and hydrating cleansers, creams, lotions, serums, and toners. Lifestyle products improve the overall quality of life and to support active, physical and healthy lifestyles. Home products are designed to create a clean and natural living environment for the home. It generates a majority of its revenue from Hong Kong and rest from China, Taiwan, Japan, United States and other regions.

Share on Social Networks: